Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Institute for Genomic Medicine, |
RCV001007564 | SCV001468506 | pathogenic | Syndromic X-linked intellectual disability Snyder type | 2021-01-07 | criteria provided, single submitter | research | The c.388C>T (p.Arg130Cys) variant was identified by research whole-genome sequencing of a family trio. It is hemizygous in the male proband, and its de novo status was confirmed by Sanger sequencing. This variant is absent from the gnomAD database, and is predicted to cause a missense change that is damaging according to 20 of 22 in silico tools. The same de novo mutation was reported by Abela et al (PMID: 26174906) in male twins with SMS whose metabolic profiling revealed significant changes in spermine/spermidine pathway metabolites. Notably, the authors observed significantly elevated levels of the metabolic product of spermine synthase (N8-acetylspermidine) compared to controls. Deep targeted resequencing in our trio revealed that the mother is a ~3% mosaic for this variant. We interpret the variant as pathogenic. |
Gene |
RCV001007564 | SCV001167183 | not provided | Syndromic X-linked intellectual disability Snyder type | no assertion provided | literature only |